A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This is a Phase 2, randomized two-armed, multi-site study of 170 patients with newly diagnosed glioblastoma multiforme. Patients will be randomized 1:1 to receive Keto Diet, or Standard Anti-Cancer Diet. All patients will receive standard of care treatment for their glioblastoma. The Keto Diet intervention will be for an 18-week period and conducted by trained research dietitians. Daily ketone and glucose levels will be recorded to monitor Keto Diet adherence. This two-armed randomized multi-site study aims to provide evidence to support the hypothesis that a Keto Diet vs. Standard Anti-Cancer Diet improves overall survival in newly diagnosed glioblastoma multiforme patients who receive standard of care treatment.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18 lat lub więcej
- •Nowo rozpoznany glejiak mózgu (w ciągu 2 miesięcy od diagnozy)
- •Nie rozpoczęta chemioterapia ani radioterapia
- •Ogólny stan zdrowia pozwalający na udział w badaniu (KPS ≥ 70)
- •Możliwość czytania i rozumienia instrukcji w języku angielskim lub hiszpańskim
- •Świadoma zgoda na udział w badaniu
✗ Disqualifies
- •Glejiak nawracający (powrót nowotworu)
- •Zaburzenia metabolizmu tłuszczów
- •Niemożność zmniejszenia dawki sterydów poniżej 8 mg dziennie
- •Wskaźnik masy ciała poniżej 21 kg/m²
- •Ciąża lub karmienie piersią
- •Uczestnictwo w innym eksperymentalnym leczeniu
- •Urządzenia medyczne incompatybilne z rezonansem magnetycznym (rozrusznik serca, implanty)
- •Preferencje żywieniowe niezgodne z dietą ketogeniczną
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 5, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (5)
Cedars-Sinai Medical Center
Los Angeles, United States
University of California, San Francisco
San Francisco, United States
Pacific Neuroscience Institute / Saint John's Cancer Institute
Santa Monica, United States
Duke University
Durham, United States
Medical College of Wisconsin
Milwaukee, United States
Trial contact
Clinical Trial Recruitment Navigator
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/6/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.